Federal Register: Recommendations for Premarket Notifications for Lamotrigine and Zonisamide Assays; Guidance for Industry and Food and Drug Administration Staff; Availability

The FDA is announcing the availability of the guidance ``Recommendations for Premarket Notifications for Lamotrigine and Zonisamide Assays.'' This guidance document discusses information to be included in premarket notifications for zonisamide or lamot...
Source: Food and Drug Adminstration (FDA): CDRHNew - Category: Medical Equipment Source Type: news